(Q24234725)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

review article

1 reference

title

Botulinum toxin injections for low-back pain and sciatica (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

author name string

Zeeshan Waseem

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Allan Gordon

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Farooq Ismail

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Geoffrey Sheean

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

Andrea D Furlan

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

publication date

19 January 2011

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

Cochrane Database of Systematic Reviews

20 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

20 January 2020

page(s)

CD008257

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:21249702%20AND%20SRC:MED&resulttype=core&format=json

BOTOX and physical therapy in the treatment of piriformis syndrome

20 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Botulinum toxin A and chronic low back pain: a randomized, double-blind study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Use of botulinum toxin in the treatment of chronic myofascial pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Botulinum neurotoxin type B and physical therapy in the treatment of piriformis syndrome: a dose-finding study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Efficacy and safety of a single botulinum type A toxin complex treatment (Dysport) for the relief of upper back myofascial pain syndrome: results from a randomized double-blind placebo-controlled multicentre study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Treatment of refractory, chronic low back pain with botulinum neurotoxin A: an open-label, pilot study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Botulinum toxin type B in piriformis syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Therapeutic use of botulinum toxin type A in treating neck and upper-back pain of myofascial origin: a pilot study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Low-dose botulinum toxin type A for the treatment of refractory piriformis syndrome.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Chapter 4. European guidelines for the management of chronic nonspecific low back pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Evidence for antinociceptive activity of botulinum toxin type A in pain management

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Grading quality of evidence and strength of recommendations

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Interventional therapies, surgery, and interdisciplinary rehabilitation for low back pain: an evidence-based clinical practice guideline from the American Pain Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Subcutaneous administration of botulinum toxin A reduces formalin-induced pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

A systematic review of low back pain cost of illness studies in the United States and internationally

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Back pain prevalence and visit rates: estimates from U.S. national surveys, 2002.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

2009 updated method guidelines for systematic reviews in the Cochrane Back Review Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Evidence based medicine in the use of botulinum toxin for back pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Estimates and patterns of direct health care expenditures among individuals with back pain in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Assessment: Botulinum neurotoxin in the treatment of autonomic disorders and pain (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Botulinum toxin for subacute/chronic neck pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Assessment: Botulinum neurotoxin for the treatment of movement disorders (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Assessment: Botulinum neurotoxin for the treatment of spasticity (an evidence-based review): report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

A randomized, double-blind, prospective pilot study of botulinum toxin injection for refractory, unilateral, cervicothoracic, paraspinal, myofascial pain syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

Treatment of Chronic Low Back Pain With Successive Injections of Botulinum Toxin A Over 6 Months

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

CT-guided injection of botulinic toxin for percutaneous therapy of piriformis muscle syndrome with preliminary MRI results about denervative process.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2

inferred from DOI database lookup

7 January 2021

based on heuristic

Low back ache treatment with botulinum neurotoxin type A. Local experience in Kuwait

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008257.PUB2